title: Unanswered questions in the management of axial spondyloarthritis: an opinion piece.
authors.forename: Xenofon
authors.initials: X
authors.lastname: Baraliakos
authors.forename: Atul
authors.initials: A
authors.lastname: Deodhar
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001368:Axis, Cervical Vertebra; D001688:Biological Products / Q000627:therapeutic use; D059451:Biosimilar Pharmaceuticals / Q000627:therapeutic use; D019468:Disease Management; D018450:Disease Progression; D006801:Humans; D025241:Spondylarthritis / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D001688:Biological Products; D059451:Biosimilar Pharmaceuticals; D014409:Tumor Necrosis Factor-alpha